Purchases and Sales Made in Q4 2024 in Sangamo Therapeutics, Inc (SGMO)
This table provides information about the institutional ownership of Sangamo Therapeutics, Inc (SGMO) during Q4 2024. The information is specifically focused on institutions that hold shares of SANGAMO THERAPEUTICS, INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-2.02M- 85.68% |
$1.57M - $5.79M
|
337K
$162K
|
|
|
Feb 13, 2025
Q4 2024
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-10.2M- 52.52% |
$7.96M - $29.3M
|
9.23M
$4.43M
|